Page 13 - Dc Therapeutics Announces Fda Approval Of Zynlonta Loncastuximab Tesirine Lpyl In Relapsed Or Refractory Diffuse Largeb Cell Lymphoma News Today : Breaking News, Live Updates & Top Stories | Vimarsana